Ikarian Capital’s Larimar Therapeutics LRMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-58,526	Closed	-$126K	–	170
2025 Q1	$126K	Hold	58,526	–	–	0.02%	149
2024 Q4	$226K	Sell	58,526 -2	-0%	-$13	0.03%	148
2024 Q3	$383K	Sell	58,528 -265,000	-82%	-$2.13M	0.05%	122
2024 Q2	$2.35M	Sell	323,528 -115,000	-26%	-$881K	0.41%	52
2024 Q1	$3.33M	Sell	438,528 -164,340	-27%	-$1.28M	0.36%	67
2023 Q4	$2.74M	Sell	602,868 -80,000	-12%	-$270K	0.26%	77
2023 Q3	$2.7M	Buy	+682,868	New	+$2.58M	0.32%	70
2022 Q3	–	Sell	-51,606	Closed	-$100K	–	141
2022 Q2	$100K	Hold	51,606	–	–	0.02%	130
2022 Q1	$209K	Buy	51,606 +4,413	+9%	+$28.9K	0.03%	164
2021 Q4	$510K	Hold	47,193	–	–	0.08%	126
2021 Q3	$545K	Sell	47,193 -5,775	-11%	-$69.3K	0.04%	182
2021 Q2	$520K	Sell	52,968 -372,416	-88%	-$4.21M	0.04%	186
2021 Q1	$6.21M	Buy	+425,384	New	+$7.73M	0.21%	107